Literature DB >> 31158374

Toward More Accurate Nomenclature for Fatty Liver Diseases.

Mohammed Eslam1, Arun J Sanyal2, Jacob George3.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31158374     DOI: 10.1053/j.gastro.2019.05.064

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  25 in total

1.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

Review 2.  Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight.

Authors:  Mohammed Eslam; Hashem B El-Serag; Sven Francque; Shiv K Sarin; Lai Wei; Elisabetta Bugianesi; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-16       Impact factor: 73.082

Review 3.  Current status and challenges in the drug treatment for fibrotic nonalcoholic steatohepatitis.

Authors:  Yi-Wen Shi; Jian-Gao Fan
Journal:  Acta Pharmacol Sin       Date:  2021-12-14       Impact factor: 7.169

4.  Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients?

Authors:  Takumi Kawaguchi; Takuji Torimura
Journal:  J Gastroenterol       Date:  2019-11-28       Impact factor: 7.527

Review 5.  Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past.

Authors:  Oyekoya T Ayonrinde
Journal:  JHEP Rep       Date:  2021-02-26

6.  Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD).

Authors:  Nahum Méndez-Sánchez; Luis Enrique Díaz-Orozco
Journal:  Med Sci Monit       Date:  2021-07-12

7.  Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.

Authors:  Elena Buzzetti; Audrey Linden; Lawrence Mj Best; Angela M Madden; Danielle Roberts; Thomas J G Chase; Suzanne C Freeman; Nicola J Cooper; Alex J Sutton; Dominic Fritche; Elisabeth Jane Milne; Kathy Wright; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-06-11

8.  Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.

Authors:  Oluyemi Komolafe; Elena Buzzetti; Audrey Linden; Lawrence Mj Best; Angela M Madden; Danielle Roberts; Thomas Jg Chase; Dominic Fritche; Suzanne C Freeman; Nicola J Cooper; Alex J Sutton; Elisabeth Jane Milne; Kathy Wright; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-07-19

9.  Alcohol use disorders and the risk of progression of liver disease in people with hepatitis C virus infection - a systematic review.

Authors:  Laura Llamosas-Falcón; Kevin D Shield; Maya Gelovany; Jakob Manthey; Jürgen Rehm
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-06-30

10.  Fatty Liver Disease: Metabolic, Genetic, or Both?

Authors:  Heinz Zoller; Sonja Wagner; Benedikt Schaefer
Journal:  Hepatol Commun       Date:  2020-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.